Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
Urologic Oncology|December 17, 2013
Does increasing life expectancy affect competing mortality after radical prostatectomy?Michael Froehner, Rainer Koch, Manfred P Wirth, et al.
Urologic Oncology|January 2, 2009
Survival analysis in men undergoing radical prostatectomy at an age of 70 years or olderMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Urology|January 27, 2009
Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controlsSven Oehlschläger, Susanne Fuessel, Axel Meye, et al.
World Journal of Urology|March 18, 2022
Acceptance and efficacy of recommended adjuvant radiotherapy in patients with positive lymph nodes at radical prostatectomy: a preference-based studyMichael Froehner, Yasmine Coressel, Rainer Koch, et al.
BJU International|June 21, 2005
Expression of Ki-67 in squamous cell carcinoma of the penisNavid Berdjis, Axel Meye, Johannes Nippgen, et al.
Urologia Internationalis|August 5, 2006
Comparison of transperitoneal versus retroperitoneal approach in laparoscopic radical nephrectomy for renal cell carcinoma: a single-center experience of 63 casesNavid Berdjis, Oliver W Hakenberg, Steffen Leike, et al.
BMC Urology|April 1, 2014
A combined index to classify prognostic comorbidity in candidates for radical prostatectomyMichael Froehner, Anna-Elisa Kellner, Rainer Koch, et al.
European Urology|December 7, 2007
Advances in specific immunotherapy for prostate cancerAndrea Kiessling, Susanne Füssel, Rebekka Wehner, et al.
Experimental and Molecular Pathology|April 2, 2013
Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanismsAlbert Hagelgans, Mario Menschikowski, Susanne Fuessel, et al.
Urologia Internationalis|February 1, 2013
Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of ageVladimir Novotny, Oliver W Hakenberg, Michael Froehner, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
Urologic Oncology|December 17, 2013
Does increasing life expectancy affect competing mortality after radical prostatectomy?Michael Froehner, Rainer Koch, Manfred P Wirth, et al.
Urologic Oncology|January 2, 2009
Survival analysis in men undergoing radical prostatectomy at an age of 70 years or olderMichael Froehner, Rainer Koch, Rainer J Litz, et al.
Urology|January 27, 2009
Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controlsSven Oehlschläger, Susanne Fuessel, Axel Meye, et al.
World Journal of Urology|March 18, 2022
Acceptance and efficacy of recommended adjuvant radiotherapy in patients with positive lymph nodes at radical prostatectomy: a preference-based studyMichael Froehner, Yasmine Coressel, Rainer Koch, et al.
BJU International|June 21, 2005
Expression of Ki-67 in squamous cell carcinoma of the penisNavid Berdjis, Axel Meye, Johannes Nippgen, et al.
Urologia Internationalis|August 5, 2006
Comparison of transperitoneal versus retroperitoneal approach in laparoscopic radical nephrectomy for renal cell carcinoma: a single-center experience of 63 casesNavid Berdjis, Oliver W Hakenberg, Steffen Leike, et al.
BMC Urology|April 1, 2014
A combined index to classify prognostic comorbidity in candidates for radical prostatectomyMichael Froehner, Anna-Elisa Kellner, Rainer Koch, et al.
European Urology|December 7, 2007
Advances in specific immunotherapy for prostate cancerAndrea Kiessling, Susanne Füssel, Rebekka Wehner, et al.
Experimental and Molecular Pathology|April 2, 2013
Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanismsAlbert Hagelgans, Mario Menschikowski, Susanne Fuessel, et al.
Urologia Internationalis|February 1, 2013
Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of ageVladimir Novotny, Oliver W Hakenberg, Michael Froehner, et al.
Pageof 28